Metamizole use during first trimester—A prospective observational cohort study on pregnancy outcome

Abstract

Metamizole exposure in the first trimester does not seem to bear a substantial teratogenic risk. Our study results support reassurance in those instances where metamizole has been used during an unrecognized pregnancy or where its use appears indispensable.